April 2013 | Page 2 Of 3 | Shrader & Associates L.L.P.
Get in Touch Today
866-262-8170
Clinical Trials for Mesothelioma

Clinical Trials for Mesothelioma

by | Apr 10, 2013 | Mesothelioma

Mesothelioma is a rare and devastating form of cancer for which there is no cure and only an 18-month life expectancy after diagnosis. Standard cancer treatments such as surgery, chemotherapy, and radiation can help, but doctors and scientists are always searching for novel treatments that may offer hope to mesothelioma patients and their families. In some cases, current mesothelioma patients...

View Article

Chemotherapy as Mesothelioma Treatment

by | Apr 6, 2013 | Mesothelioma

Chemotherapy is one of the main treatments administered to mesothelioma patients. There are two ways chemotherapy is used to treat mesothelioma. In systemic therapy, chemotherapy is injected into the patient’s vein. From there, it travels through the body to reach and kill cancer cells, wherever they are. The other way chemotherapy is administered to mesothelioma patients is that it is placed...

View Article

Pakistan could Ban Asbestos

by | Apr 4, 2013 | Mesothelioma

Pakistan officials could be close to banning asbestos, a deadly mineral that is the cause of mesothelioma and other potentially fatal diseases like asbestosis. Pakistan’s National Assembly’s Standing Committee on Human Resource Development is recommending that the country permanently ban the use and importation of asbestos. The recommendation comes on the heels of a series of hearings about...

View Article

Biomarker Could Help Chemo-Resistance in Mesothelioma Patients

by | Apr 4, 2013 | Mesothelioma

Chemotherapy is the most commonly prescribed treatment to slow disease growth and reduce symptoms in mesothelioma and lung cancer patients, but is often rendered ineffective when a disease becomes chemo-resistant. Now, researchers could have identified a biomarker that “may be a target for overcoming drug resistance in cancer.” The biomarker can help doctors and researchers evaluate patient...

View Article

Pre-Chemo Drug Combo May Increase Mesothelioma Survival Rate

by | Apr 4, 2013 | Mesothelioma

A study recently published by Italian researchers in Anticancer Research found that one combination of neoadjuvant chemotherapy drugs may give patients a longer mesothelioma life expectancy than another. Usually administered with a platinum-based drug, Alimta (antimetabolite pemetrexed) can be used before surgery (newadjuvant) with the goal of shrinking a tumor to improve surgery success, or...

View Article